Panel discussion MedtecLIVE 2024

How can German medical technology remain innovative?

The functioning interaction between innovators and clinical users is of central importance for the innovative strength of medical technology. This interaction is coming under increasing pressure for a variety of reasons against the backdrop of the further development of healthcare systems. The growing demand for individualised and digitalised applications requires innovators to gain a far greater insight into everyday healthcare. Several of the industry-in-clinic platforms funded by the Federal Ministry of Education and Research are discussing this and contributing their experience.

The discussion will be moderated by Ms. Carina Bastuck.

Please note: the panel discussion will be held in German.

Supported by: Federal Ministry of Education and Research


Speakers (6)

Dr. Marco Wendel

Dr. Marco Wendel

CEO FastTrack MedTech GmbH

Dr. Christoph Monfeld

Dr. Christoph Monfeld

Managing director neuroMIT

Prof. Dr. med. Thomas Picht

Prof. Dr. med. Thomas Picht

Director CEED

Dr. Michael Buschermöhle

Dr. Michael Buschermöhle

Managing Director KIZMO GmbH

Dr. med. Simon Weidert

Dr. med. Simon Weidert

Managing Director m3i GmbH

Dr. Paul Martin Weigl

Dr. Paul Martin Weigl

Managing Director & CEO MECEOR GmbH